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Abstract Type D personality has been associated with
poor prognosis in cardiac patients. This study investigated
the validity of the Type D construct in Iceland and its asso-
ciation with disease severity and health-related risk markers
in cardiac patients. A sample of 1,452 cardiac patients
completed the Type D scale (DS14), and a subgroup of 161
patients completed measurements for the ﬁve-factor model
of personality, emotional control, anxiety, depression, stress
and lifestyle factors. The Icelandic DS14 had good psycho-
metric properties and its construct validity was conﬁrmed.
Prevalence of Type D was 26–29%, and assessment of Type
D personality was not confounded by severity of underlying
coronary artery disease. Regarding risk markers, Type D
patients reported more psychopharmacological medication
useandsmoking,butfrequencyofpreviousmentalproblems
was similar across groups. Type D is a valid personality
construct in Iceland, and is associated with health-related
risk markers, but not cardiac disease severity.
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Introduction
Coronary heart disease is one of the leading causes of
mortality in the world today (MacKay & Mensah, 2004;
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DOI 10.1007/s10865-011-9337-5Murray & Lopez, 1997), and although new cardiac treat-
ments have helped ﬁght coronary heart disease in recent
years, an estimated 1/3 of coronary heart disease risk fac-
tors remain elusive (Gudnason, 2004). The addition of
psychological factors to standard biomedical risk factors
may enhance the prediction of patients at risk. Initial
research on the Type A behavior pattern suggested that
psychological factors were related to increased risk of
heart attacks, but further investigations on Type A behavior
were inconclusive (Rozanski et al., 1999). Subsequently,
researchers turned their focus towards isolated factors
such as hostility, depression, anxiety, social isolation, and
chronic stress (Matthews, 2005; Rozanski et al., 1999,
2005; Strike & Steptoe, 2004) to document a relationship
between psychological factors and poor cardiac prognosis
(Rozanski et al., 2005).
Clustering of psychological factors within individuals
enhances the risk of adverse health outcomes (Rozanski
et al., 2005; Strike & Steptoe, 2004), and this clustering
may partly be attributed to a speciﬁc vulnerability in the
realm of personality (Dimsdale, 2008). The distressed
(Type D) personality construct was originally developed to
identify cardiac patients who are vulnerable to emotional
and interpersonal difﬁculties (Denollet, 1993; Denollet
et al., 1996). Type D individuals tend to experience neg-
ative emotions (elevated score on negative affectivity)
while not discussing them with others due to fear of
rejection (elevated score on social inhibition) (Denollet
et al., 1996). Type D personality has been associated with
poor quality of life and increased morbidity and mortality
in cardiac patients (Denollet et al., 1996, 2006b; Kupper &
Denollet, 2007; Pedersen & Denollet, 2006). The preva-
lence of Type D ranges from 28 to 32% across different
cardiovascular conditions, including ischemic heart dis-
ease, chronic heart failure, and peripheral artery disease.
The mortality risk incurred by Type D is 3-fold, with this
risk being independent of disease severity, such as left
ventricular dysfunction, and mood states such as anxiety
and depression, and despite appropriate medical treatment
(Pedersen & Denollet, 2006).
The mechanisms relating Type D personality with
adverse prognosis in cardiac patients are generally not
thought to derive from worse disease severity (de Jonge
et al., 2007; Nicholson et al., 2006). Rather, negative
health-related behaviors, such as smoking and poor treat-
ment adherence (Kirkcaldy et al., 2002; Pedersen et al.,
2007a; Schiffer et al., 2007), and dynamic physiological
processes such as elevated cortisol levels (Molloy et al.,
2008; Whitehead et al., 2007) and pro-inﬂammatory cyto-
kines (Denollet et al., 2009) have been suggested as pos-
sible contributing factors. Importantly, recent ﬁndings have
casted doubt on the utility of using extent of coronary
atherosclerosis as a surrogate means for inferring associa-
tions between psychological risk factors and adverse car-
diovascular outcomes in cross-sectional data (Rozanski
et al., 2011). In the present study, we included assessment
of extent of coronary artery disease to rule out the possi-
bility of reverse causation, whereby disease severity can
contribute to greater psychological distress and, in turn,
may confound the assessment of Type D personality traits.
In clinical and epidemiological research, Type D can be
assessed with the standardized 14-item Type D Scale
(DS14) that measures negative affectivity and social inhi-
bition (7 items for each domain) (Denollet, 2005). The
DS14 scale has been validated in Belgian (Denollet, 2005),
Chinese (Yu et al., 2008), Danish (Pedersen & Denollet,
2004; Spindler et al., 2009), Dutch (Denollet, 2005), Ger-
man (Grande et al., 2004), Italian (Gremigni & Sommaruga,
2004) and Ukrainian (Pedersen et al., 2009) cardiac patients
and healthy controls. However, only a few studies have
examined how the Type D construct ﬁts within the ﬁve-
factor model of personality, and no study to date has tested
how the social inhibition factor relates to emotional control.
Hence, the objectives of the current study were (a) to
evaluate the psychometric properties of the DS14 in Ice-
landic cardiac patients with a speciﬁc focus on the construct
validity of Type D, (b) to examine whether assessment of
Type D personality is confounded by worse disease severity
in these patients and (c) to explore the association between
Type D and health-related risk markers.
Method
Participants
This study included two cardiac patient samples. The ﬁrst
sample (cardiac sample I) consisted of 1,291 patients
hospitalized for coronary angiography and/or percutaneous
coronary intervention at Landspitali-university hospital in
Reykjavik (May 2007–June 2008), the only hospital in
Iceland where such operations are performed. These
patients were approached when hospitalized to the coronary
care unit, upon arrival to the emergency ward or by mail if
they were on the waiting list for a coronary catheterization.
Patients were eligible for participation only if they
(a) underwent a coronary angiography or percutaneous cor-
onary intervention during their current hospitalization; and
(b) spoke and read Icelandic ﬂuently. Forty-four patients
were excluded because they either did not complete the
DS14 (n = 34) or did not undergo coronary angiography
(n = 10). The remaining 1,247 patients (875 men and 372
women) had a mean age of 64.8 years (SD 10.8), with wo-
menbeingsigniﬁcantlyolderthanmen(M = 63.3(SD11.0)
vs. M = 68.2 (SD 9.5), t(1,245) = 7.57, P\0.001). This
156 J Behav Med (2012) 35:155–166
123patient sample was included in the study to (a) estimate the
factor structure of the DS14 scale, and (b) examine whether
the assessment of Type D personality is confounded by the
severity of underlying coronary artery disease.
The second sample (cardiac sample II) consisted of
161 patients from the coronary care unit, and from the
heart failure clinic of the Landspitali-university hospital
(February–March 2006 and November 2006–April 2007).
This sample was included in the study to examine more
extensively the validity of the Type D personality construct
in Iceland, and how it is related to health-related risk
markers. To this end, these patients completed additional
measurements that were not administered in the larger
cardiac sample I. Four patients were excluded from anal-
ysis due to incomplete questionnaire data. The ﬁnal sample
included 157 participants (118 males and 39 females) with
an average age of 61.7 years (SD 11.3), and again women
tended to be older than men (M = 60.2 (SD 11.1) vs.
M = 66.4 (SD 11.0), t(150) = 3.03, P\0.01).
Baseline characteristics for the two participant samples
are presented in Table 1. Patients in cardiac sample I were
older on average compared to patients in cardiac sample II
(t(1,397) = 3.24; P B 0.001), but gender distribution was
similar in the two samples (v2
ð1;n¼1;404Þ = 1.68, P = 0.20).
The majority of patients in cardiac sample I had coronary
artery disease (55%) or had experienced one or more heart
attacks (23%), while patients with a history of one or more
heart attacks (41%) and heart failure (24%) were more
prominent in cardiac sample II.
The study protocol was approved by the medical ethics
committee of the National Bioethics Committee in Iceland.
The study was conducted to conform to the ethical tenets
developed by the World Medical Association, as espoused
in the Declaration of Helsinki. All patients provided written
informed consent.
The DS14 scale
The DS14 is a 14-item questionnaire comprised of two
seven-item subscales (Denollet, 2005), measuring the
tendency to (a) experience negative emotions (negative
affectivity) and (b) inhibit self-expression in social inter-
actions (social inhibition). The answering format is on a
ﬁve-point Likert scale, ranging from 0 (false)t o4( true),
with total scores ranging from 0 to 28 for each subscale.
Items include ‘‘I am often irritated’’ (negative affectivity)
and ‘‘I am a closed kind of person’’ (social inhibition). The
original Dutch DS14 was translated into Icelandic by four
researchers. They received aid from two ﬂuent Dutch
speakers who independently translated the DS14 items
from Dutch to Icelandic; a translation group examined the
two independent translations, and one ﬁnal version was
constructed. Subsequently, the ﬁnal Icelandic version was
back-translated and compared to the original Dutch version
to ensure accuracy.
Participants were deﬁned as having a Type D person-
ality if they scored C10 on both negative affectivity and
social inhibition. This cut-off value has been used in pre-
vious research (Denollet, 2005; Emons et al., 2007), and is
derived from the median split on negative affectivity and
social inhibition scores of participants in those studies. A
recent study using item-response theory has shown the cut-
off C10 on both subscales to be the best to distinguish
between Type D and non-Type D individuals, as all items
had the highest measurement accuracy around that cut-off
(Emons et al., 2007).
Construct validity
To evaluate the construct validity of the Icelandic DS14
scale, the NEO-ﬁve-factor inventory (NEO-FFI) (Costa &
McCrae, 1989), emotional control questionnaire (ECQ)
(Roger & Najarian, 1989; Roger & Nesshoever, 1987),
hospital anxiety depression scale (HADS) (Zigmond &
Snaith, 1983) and perceived stress scale (PSS) (Cohen
et al., 1983) were administered in Cardiac sample II.
The NEO-FFI is a 60-item self-report scale which
assesses ﬁve broad personality traits from the ﬁve-factor
model of personality, that is neuroticism (e.g. anxiety,
impulsiveness, vulnerability), extraversion (e.g. sociability,
activity, positive emotions), openness (e.g. fantasy,
feelings, artistic), agreeableness (e.g. trust, straightfor-
wardness, altruism) and conscientiousness (e.g. achieve-
ment striving, dutifulness, self-discipline) (Costa &
McCrae, 1989). The scale contains 12 statements for each
Table 1 Baseline characteristics
Cardiac sample I
(n = 1,247)
Cardiac sample II
(n = 157)
Age (years)
Mean (SD) 64.8 (10.8) 61.7 (11.3)
Gender
Males 70% (875) 75% (118)
Heart disease
Heart failure 2% (22) 24% (38)
Pacemaker and
cardiac arrhythmia
7% (89) 11% (17)
C1 heart attacks 23% (290) 41% (64)
Coronary artery disease 55% (678) 10% (16)
Hypertension 7% (92) 11% (17)
No disease 6% (73) 0 (0%)
Unknown 0.2% (3) 3% (5)
Data are presented as percentages (n) unless otherwise speciﬁed
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123trait, and respondents answer on a ﬁve-point Likert scale
(ranging from strongly disagree (0) to strongly agree (4))
how each statement refers to them. The psychometric
properties of the Icelandic version of the NEO-FFI are
acceptable and the test–retest reliability and internal con-
sistency deemed sufﬁcient (Jo ´nsson, 2005), with Cron-
bach’s alpha ranging from 0.71 to 0.88 for the ﬁve traits
(Svansdo ´ttir, 2006).
The emotional control questionnaire or ECQ measures
how easily people express and control their emotions
(Roger & Najarian, 1989; Roger & Nesshoever, 1987). The
scale includes 56 items which are divided into four factors
(emotional inhibition, aggression control, benign control
and rehearsal), but in this study a shorter 20-item version
measuring rehearsal and emotional inhibition only was
used (Roger et al., 2001). Rehearsal refers to the tendency
of individuals to ruminate over emotionally distressing
events while emotional inhibition assesses to what extent
people express their emotions. The response format for
each item ranges from strongly disagree (1) to strongly
agree (4). The Icelandic version of this scale has adequate
psychometric properties with Cronbach’s alpha reliability
coefﬁcients of a = 0.83 for rehearsal and a = 0.74 for
emotional inhibition (Ingibergsdo ´ttir, 2003).
The HADS is a 14-item questionnaire that measures
symptoms of depression and anxiety in physically ill people
(Zigmond&Snaith,1983).Thequestionnairecontainsseven
statements for each mood status. Participants rate on a four-
point scale (0–3) how well each statement refers to them.
Total scores range from 0 to 21 for each domain. The Ice-
landic version of the HADS identiﬁes symptoms of depres-
sionandanxietysufﬁcientlywell(Schaaberetal.,1990),with
reliability estimates ranging from a = 0.78–0.86 for anxiety
and a = 0.65–0.85 for depression (Smari et al., 2008).
The PSS or perceived stress scale is a 14-item measure of
self-appraised stress (Cohen et al., 1983). Items include for
instance ‘‘In the last month, how often have you felt that you
wereunabletocontroltheimportantthingsinyourlife?’’The
response format is on a ﬁve-point Likert scale ranging from
never(0)toveryoften(4),andtotalscoresrangefrom0to56.
The scale has good psychometric properties (Cohen et al.,
1983;Cohen&Williamson,1988)andcorrelateswithsocial
anxiety and depression symptoms (Cohen et al., 1983). The
Icelandic version of PSS has comparable psychometric
properties to the original language version (Davı ´ðsdo ´ttir &
Bachman, 1991) with Cronbach’s alpha = 0.89 in a uni-
versity student sample (Svansdo ´ttir, 2006).
Disease severity
Disease severity, deﬁned by how many coronary arteries
were affected by coronary artery disease (i.e. normal
arteries, 1, 2, or 3 arteries affected, and main stem
narrowing) was derived from results of the coronary
angiography in cardiac sample I. Angiography results were
inconclusive for one person, which was excluded from this
analysis. Information on disease classiﬁcation, categorized
as hypertension, coronary artery disease, previous heart
attacks, pacemaker/arrhythmias and heart failure, was
obtained from medical staff and/or retrieved from medical
records. Information concerning disease classiﬁcation was
missing for three patients in cardiac sample I (0.2%) and
ﬁve patients in cardiac sample II (3.2%).
Health-related risk markers
Participants in cardiac sample II provided information by
self-report regarding certain health-related risk markers.
These included (a) smoking status (never, ex-smoker,
current smoker); (b) amount of smoking per day (0–10
cigarettes, 10–20 cigarettes, 20–30 cigarettes, and [30
cigarettes a day); (c) duration of smoking (0–5 years,
5–10 years, 10–20 years,[20 years); (d) previous mental
problems, i.e. ‘‘Have you experienced any signiﬁcant
mental problems in the past?’’ (yes, no); and (e) psycho-
pharmacological medication use, i.e. ‘‘Have you used one
or more of the following medications for more than two
weeks in the past 12 months: sleeping pills, anxiety-
reducing medications, antidepressants and sedatives?’’ (no,
sleeping pills, anxiety-reducing medication, antidepres-
sants, sedatives). Of note, due to a low incidence rate for
each medication category, answers were recoded post-hoc
to a binary variable containing the following distinction:
no, I have not used any of these medications; yes, I have
used one or more of these medications.
Statistical analysis
Principal axis factor analysis with direct oblimin rotation
(delta = 0) was used to explore the factor structure of the
DS14, using the scree plot and criterion of eigenvalues[1
to determine the number of factors to extract. A conﬁr-
matory factor analysis of the scale was performed to con-
ﬁrm the two-factor structure of the scale, using structural
equation modeling (SEM) and the maximum likelihood
method in AMOS 17 (Analysis of Moment Structures,
Chicago, IL, USA). In the construction of the model, the
theoretical foundation of the scale was taken into account.
As the negative affectivity and social inhibition subscales
each cover three different facets of negative affectivity and
social inhibition, respectively, error covariance was added
to items representing each facet, i.e. for items measuring
the negative affectivity facets dysphoria (items 4, 7 and
13), worry (items 2 and 12) and irritability (items 5 and 9),
and for items measuring the social inhibition facets
158 J Behav Med (2012) 35:155–166
123discomfort in social interactions (6, 8 and 14), reticence (10
and 11) and social poise (items 1 and 3). Goodness of ﬁt
indexes used in the analysis included the Chi-square, the
Comparative ﬁt index (CIF) and the Root mean square
error of approximation (RMSEA). For Chi-square, a
value C 0.05 indicates good ﬁt (agreement with the null
hypotheses that residuals are minimal and the data ﬁt the
model well). The Chi-square is inﬂuenced by sample size,
which can lead to inﬂated Chi-square values and thus sta-
tistical signiﬁcance, indicating bad ﬁt (Schumacker &
Lomax, 2004). For the CFI, values close to 1 indicate a
very good ﬁt and values above 0.90 or close to 0.95 good
ﬁt. The RMSEA index should be B0.05 to indicate good ﬁt,
but levels B0.08 are considered to indicate adequate ﬁt.
Internal consistency of the scale was assessed with Mean
inter-item correlation and Cronbach’s alpha.
Validity of the DS14 was estimated by exploring the
Pearson’s correlation between the negative affectivity and
social inhibition subscales and similar constructs, i.e.
neuroticism and extraversion, emotional inhibition and
rehearsal, anxiety and depression and perceived stress. A
factor analysis of scale scores on the DS14 scale, NEO-
FFI, ECQ, HADS and PSS was executed to verify that
(a) negative affectivity, neuroticism and rehearsal, and
(b) social inhibition, introversion and emotional inhibition
measure related constructs, and to test how anxiety,
depression and stress would relate to the negative affec-
tivity and social inhibition factors. Differences in disease
classiﬁcation by Type D personality were assessed with
Kendall’s Tau-c calculations, but patients with arrhyth-
mias and pacemakers were excluded from the analysis
due to the different nature of their disease. The Kendall’s
Tau-c was also employed to estimate differences in dis-
ease severity by Type D personality in cardiac sample I,
in both the entire sample and among patients who had
established coronary artery disease. Finally, Type D and
non-Type D patients in cardiacsampleIIwerecomparedon
smoking behavior, prevalence of previous mental problems,
and medication use with Chi-square tests for nominal vari-
ables and Tau-c for ordinal variables. Association strength
was estimated with Cohen’s D calculations for quantitative
variablesandoddsratiosforcategoricalvariables.TheSPSS
17 statistical software for Windows was used for all main
analysis (Statistical Package for Social Sciences, Chicago,
IL, USA).
Results
Factor structure of the DS14
A principal axis factor analysis (direct oblimin rotation,
delta = 0) in a combined sample of cardiac patients
(n = 1,404) indicated a two-factor solution, which ex-
plained 46% of variance in the patient sample. These two
factors clearly reﬂected the negative affectivity and social
inhibition subscales, with satisfactory factor loadings
(ranging from 0.47 to 0.75) and good internal consistency
(negative affectivity: Cronbach’s alpha = 0.85 and Mean
inter-item correlation = 0.45; social inhibition: Cron-
bach’s alpha = 0.84, Mean inter-item correlation = 0.43)
(Table 2).
A conﬁrmatory factor analysis of the two-factor structure
of the Icelandic DS14 in the same sample indicated a good
to adequate model ﬁt for the unconstrained model (v
2 =
435.63, P B 0.001; CFI = 0.953 and RMSEA = 0.063,
90% CI 0.058–0.069). Standardized regressional weights of
items to factor ranged from 0.52 to 0.79 for negative affec-
tivity and 0.44–0.80 for social inhibition (Fig. 1).
Construct validity
The convergent and construct validity of the Icelandic
DS14 scale was evaluated by examining correlations of
negative affectivity and social inhibition with similar
construct measurements in cardiac sample II. The negative
affectivity subscale had a high positive correlation with
neuroticism (r = 0.80) and rehearsal (r = 0.58), while
social inhibition was negatively correlated with extraver-
sion (r =- 0.65) and positively with emotional inhibition
(r = 0.50), which further supports the divergent validity of
the Type D factors and their individual attributes. Negative
affectivity had a high correlation with anxiety, depression
and stress scores, indicating that it clearly measures
increased negative affect. An axis factor analysis (direct
oblimin rotation, delta = 0) of scale scores conﬁrmed that
the negative affectivity and social inhibition subscales were
differentially related to the ﬁve-factor model of personal-
ity; negative affectivity (loading = 0.79), neuroticism
(0.78) and rehearsal (0.64) loaded on a single negative
affectivity/neuroticism factor. Social inhibition (-0.95),
extraversion (0.57) and emotional inhibition (-0.44) loa-
ded together on a separate inhibition factor. Neither DS14
subscale was related to agreeableness, conscientiousness or
openness of the ﬁve-factor model of personality. Anxiety
(-0.50), depression (-0.73) and stress (-0.60) loaded
together on a single factor termed ‘‘psychological well-
being’’, but anxiety also had a considerable loading on the
negative affectivity/neuroticism factor (0.49) (Table 3).
Prevalence of Type D personality
Average scores on negative affectivity and social inhibition
were equivalent in the two patient samples (negative
affectivity: M = 8.6 (SD 5.6) vs. M = 8.8 (SD 5.9),
J Behav Med (2012) 35:155–166 159
123t(1,402) = 0.46, P = 0.65; social inhibition: M = 9.3 (SD
5.8) vs. M = 9.3 (SD 6.1), t(1,402) = 0.11, P = 0.91; for
cardiac sample I and II, respectively). Using the cut-
off C 10 for both subscales (Denollet, 2005; Emons et al.,
2007), 26% of patients in cardiac sample I and 29% of
patients in cardiac sample II, were classiﬁed as Type D
individuals.
Confounding effect of disease severity
Assessment of Type D personality was not confounded by
severity of underlying coronary artery disease in cardiac
sample I, as estimated by number of arteries affected by
coronary artery disease from the coronary angiography
results (Tau-c = 0.010, n = 1,237, P = 0.72; Fig. 2).
About 1/3 of both non-Type D and Type D patients had
normal arteries or atheroma with no signiﬁcant occlusions,
and with those individuals excluded from the analysis,
Type D personality was still not associated with worse
disease severity (Tau-c =- 0.001, n = 838, P = 0.98).
Assessment of Type D personality was also not related
to disease classiﬁcation in cardiac sample I (Tau-c =
-0.02, n = 1,155, P = 0.45) nor cardiac sample II (Tau-
c =- 0.15, n = 135, P = 0.068). In both cases, disease
classiﬁcation was categorized as: no disease, hyperten-
sion, coronary artery disease, C1 heart attacks and heart
failure.
Association with health-related risk markers
As a ﬁnal step, we explored the relationship of Type D
personality with psychopharmacological medication use,
previous mental problems and smoking in cardiac sample
II. Type D patients reported more psychopharmacological
medication use (Fig. 3). When asked about use of sleeping
pills, anxiety-reducing medication, antidepressants and
sedatives, half of the cardiac patients with a Type D per-
sonality (51%) reported having used one or more of these
medications compared to 29% of their non-Type D coun-
terparts (v2
ð1;n¼154Þ = 6.79, P = 0.009; OR 2.59, 95% CI
1.25–5.34, P = 0.010). Prevalence of previous mental
problems did however not differ between Type D (19%)
and non-Type D (14%) patients (v2
ð1;n¼149Þ = 0.584,
P = 0.45). Type D patients were signiﬁcantly more likely
to smoke as compared with non-Type D patients (Fig. 3);
i.e., 22% versus 6% (v2
ð1;n¼156Þ = 8.35, P = 0.004; OR
4.25, 95% CI 1.50–12.00, P = 0.006). In patients with a
history of smoking, no differences were found between
Type Ds and non-Type Ds regarding how many cigarettes
they smoked per day (Tau-c = 0.11, n = 115, P = 0.26).
However, a trend towards a longer history of smoking was
noted in Type Ds (Tau-c = 0.15, n = 120; P = 0.056), but
76% of Type D smokers (former or current) reported
having smoked for 20 years or more compared to 59% of
non-Type D smokers.
Table 2 Factor analysis and
reliability of the DS14 scale in a
combined cardiac sample
(n = 1,404)
The highest loadings on the
corresponding factor,
Cronbach’s alpha and mean
inter-item correlations are
presented in bold
Factors I II
Negative affectivity items
2. I often make a fuss about unimportant things 0.61 0.10
4. I often feel unhappy 0.74 0.07
5. I am often irritated 0.73 0.04
7. I take a gloomy view of things 0.63 -0.14
9. I am often in a bad mood 0.58 -0.13
12. I often worry about something 0.60 0.02
13. I am often down in the dumps 0.73 -0.12
Cronbach’s alpha 0.85
Mean inter-item correlation 0.45
Social inhibition items
1. I make contact easily when I meet people 0.14 0.72
3. I often talk to strangers 0.16 0.61
6. I often feel inhibited in social interactions 0.29 -0.50
8. I ﬁnd it hard to start a conversation 0.10 -0.75
10. I am a closed kind of person 0.12 -0.66
11. I would rather keep other people at a distance 0.16 -0.47
14. When socializing I don’t ﬁnd the right things to talk about 0.15 -0.69
Cronbach’s alpha 0.84
Mean inter-item correlation 0.43
160 J Behav Med (2012) 35:155–166
123Discussion
The objectives of the current study were to evaluate the
psychometric properties and construct validity of the Ice-
landic DS14 scale, to test whether Type D assessment is
confounded by disease severity in Icelandic angiography
patients, and to explore the relationship between Type D
and health-related risk markers. The ﬁndings supported the
two-factor structure of the Icelandic DS14, and its validity
and reliability in this sample of Icelandic heart patients.
Principal axis factor analysis revealed internally consistent
negative affectivity and social inhibition factors, and a
conﬁrmatory factor analysis conﬁrmed the two-factor
structure of the original scale (Denollet, 2005) in a large
sample of Icelandic cardiac patients.
The current results supported the convergent and
divergent validity of the Type D construct in the Icelandic
setting. An exploratory factor analysis of scale scores
showed that negative affectivity, neuroticism and rehearsal
loaded on the same factor, while social inhibition, extra-
version, and emotional inhibition loaded together on
another factor, supporting the construct validity of the two
factors of the DS14 (Denollet, 2005; Fruyt & Denollet,
2002) whilst also strengthening its cross-cultural validity.
Furthermore, negative affectivity correlated strongly with
anxiety, depression and moderately with perceived stress,
conﬁrming the presence of increased negative mood states
within the negative affectivity trait. In addition, social
inhibition was clearly associated with emotional inhibition
as measured by the emotional control scale. In a recent
Fig. 1 Standardized regression
weights for the 2-factor model
of the DS14, representing
negative affectivity (NA) and
social inhibition (SI)
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123study, Grande et al. (2010) advocated more testing of the
construct validity of the social inhibition dimension,
especially since it is the combination of social inhibition
with negative affectivity that seems to make Type D per-
sonality a stronger predictor of adverse cardiac events
compared with other single-dimensional negative affect
factors, such as depression. In the context of Type D per-
sonality, the inhibition of emotions in social interaction is
believed to play a key part in the association with adverse
cardiac prognosis, by modulating the effect negative
emotions have on cardiac prognosis (Denollet et al.,
2006a). Others have also linked social inhibition with
social avoidance (Yu et al., 2008), lack of social boldness
(Grande et al., 2010) and suppressed anger (Denollet et al.,
2010a).
Table 3 Correlations and results of a factor analysis of scale scores for the DS14, NEO-FFI, ECQ and HADS subscales and PSS scale
Correlation Negative affectivity Social inhibition Pattern matrix
Cardiac sample II (n = 157) I II III IV V
Negative affectivity – 0.47* 0.79 -0.14 -0.09 -0.07 0.04
Social inhibition – – 0.11 20.95 0.11 -0.05 0.05
Neuroticism 0.80* 0.47* 0.78 -0.12 -0.06 -0.14 -0.13
Extraversion -0.48* -0.65* -0.09 0.57 0.12 -0.02 0.17
Agreeableness -0.33* -0.21* -0.28 -0.03 0.07 -0.35 0.17
Conscientiousness -0.20* -0.25* -0.01 0.06 0.05 0.12 0.72
Openness -0.02 -0.07 -0.02 0.06 0.01 20.45 -0.09
Rehearsal 0.58* 0.35* 0.64 -0.05 0.01 0.23 -0.02
Emotional inhibition 0.25* 0.50* -0.08 20.44 -0.19 0.25 -0.10
Anxiety 0.67* 0.26* 0.49 0.01 20.50 -0.25 0.20
Depression 0.55* 0.35* 0.04 -0.15 20.73 -0.11 -0.09
Perceived stress 0.38* 0.18* 0.04 0.05 20.60 0.23 -0.09
The highest loadings on the corresponding factor are presented in bold
NEO-FFI NEO-ﬁve-factor inventory, ECQ Emotional control questionnaire, HADS Hospital anxiety and depression scale, PSS Perceived stress
scale
* P\0.001
Fig. 2 Coronary artery disease
severity, stratiﬁed by Type D
personality
Fig. 3 Prevalence of psychopharmacological medication use and
smoking, stratiﬁed by Type D personality
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123The prevalence of Type D personality of twenty-six and
twenty-nine percent in the cardiac samples was comparable
to that found in European and Chinese samples (Denollet,
2005; Grande et al., 2004; Gremigni & Sommaruga, 2004;
Pedersen & Denollet, 2004; Pedersen et al., 2009; Spindler
et al., 2009; Yu et al., 2008). Assessment of Type D per-
sonality was not confounded by disease severity, as esti-
mated by the number of coronary arteries affected with
coronary artery disease and/or presence of signiﬁcant nar-
rowing at the main stem. This ﬁnding is in accordance with
previous results in coronary artery disease and congestive
heart failure patients, where no association has been found
between Type D personality and indicators of disease
severity, such as multivessel disease (Martens et al., 2007),
left ventricular ejection fraction (Denollet & Brutsaert,
1998; de Jonge et al. 2007) and biomedical markers (i.e.
brain natriuretic peptide) (Pelle et al., 2009). Similarly,
Type D personality was not related to disease classiﬁcation
in either of the cardiac samples. The majority of former
ﬁndings have generally also revealed that Type D person-
ality is stable across time, and does not seem to be affected
by changes in mood status or severity of cardiac disease
(Martens et al., 2007).
The lack of association between Type D personality and
extent of coronary artery disease does not necessarily
diminish the status of Type D personality as a predictor for
adverse cardiac prognosis. Conversely, these ﬁndings may
merely indicate that the mechanisms relating Type D per-
sonality with adverse prognosis do not stem from worse
disease severity, but through other pathways. Furthermore,
if disease severity were in fact the pathway through which
Type D personality affects cardiac prognosis, then the
association between Type D and prognosis should diminish
in strength or disappear altogether when multivariate
adjustments for disease severity markers are conducted.
This has however not been the case in previous studies, as
is evident in the recent review by Denollet et al. (2010b).
Mediating mechanisms linking Type D with adverse car-
diac prognosis reside more likely in behavioral and phys-
iological processes. Potential behavioral factors include
unhealthy lifestyle behaviors (Williams et al., 2008), more
smoking (Pedersen et al., 2007a), poor treatment adherence
(Rozanski et al., 2005; Williams et al., 2011) and inade-
quate consultation behavior (Schiffer et al., 2007), while
physiological and biological processes may include ele-
vated cortisol (Molloy et al., 2008; Whitehead et al., 2007),
pro-inﬂammatory cytokines (Denollet et al., 2009) and
cardiovascular stress reactivity (Denollet et al., 2010b)t o
name a few. Type D patients may thus be less likely to
follow their doctors recommendations regarding medica-
tions or changing unhealthy lifestyle behaviors, and per-
haps less efﬁcient in presenting their symptoms to their
doctor, due to their high social inhibition. Such factors
could possibly explain why these patients develop or
experience a more adverse prognosis compared to their
non-Type D counterparts.
A recent study by Rozanski et al. (2011) has also re-
ported that psychological risk factors (depression, hostility,
social support, perceived stress, job strain, and optimism)
were not associated with the extent of coronary athero-
sclerosis. This further supports the lack of association be-
tween Type D and extent of coronary artery disease in the
current study, as the Type D construct generally summa-
rizes such psychological risk factors in the general negative
emotional distress it encompasses (Suls & Bunde, 2005).
Finally, even as some researchers have disputed that the
relation of psychological factors with cardiovascular
prognosis is confounded by worse somatic health, ﬁndings
from a recent study have indicated that the Type D per-
sonality construct is less confounded by somatic health
compared with depression (de Jonge et al. 2007).
Type D personality had strong ties to health-related risk
markers in cardiac patients. Although no association
was found between Type D personality and prevalence of
reported previous mental problems in the current study,
psychopharmacological medication use was higher among
Type D patients compared to their non-Type D counter-
parts, and a high correlation emerged between negative
affectivity and anxiety and depression. Previously, research-
ers have also found that post-myocardial infarction patients
with a Type D personality were signiﬁcantly more likely to
use benzodiazepines as compared to non-Type D patients
(Denollet et al., 1995). The lack of association with former
mental problems seems contradictory with the high corre-
lation noted between negative affectivity and anxiety
and depression. The assessment of previous mental prob-
lems may not adequately portray the number of previously
diagnosed mental problems, due to the simplistic one
question format assessment.
We also found a relationship between Type D personality
and smoking among cardiac patients. Incidence of current
smoking was higher in the Type D patient group, and there
were some indications that Type D smokers had a longer
history of smoking compared to non-Type D smokers.
Previously, it has been reported that cardiac patients with a
Type D personality may be more likely to smoke (Pedersen
et al., 2007b), and that Type D individuals are less likely
to engage in healthy lifestyle behaviors (Williams et al.,
2008). These ﬁndings suggest that cardiac patients with
Type D personality may struggle more with the lifestyle
changes recommended by doctors to decrease likelihood of
further cardiac events. In addition, previous results have
indicated that heart failure patients with Type D personality
are more likely to show inadequate consultation behavior
compared to non-Type D patients (Pelle et al., 2010;
Schiffer et al., 2007), which implies that self-management
J Behav Med (2012) 35:155–166 163
123and medical adherence in these patients may be impaired as
well. Nevertheless, research results have indicated that the
adverse effect of Type D on cardiac prognosis (Pedersen
et al., 2007b) and poor health status (Pedersen et al., 2007a)
remains signiﬁcant despite statistical adjustment for
smoking and other mechanisms that may mediate the rela-
tionship between Type D and health outcomes. More re-
search needs to be conducted to clarify which mediating
mechanisms are behind Type D’s association with adverse
prognosis in cardiac patients, and to determine whether
health-behavior and/or poor medical adherence play a sig-
niﬁcant role.
Certainlimitationsrestricttheinterpretationofthepresent
ﬁndings. First of all, the participant samples were not ran-
domly selected. Yet, cardiac sample I included consecutive
patients nationwide in Iceland, which diminished greatly
theriskofselectionbiasinthatsample.Anotherlimitationis
the self-report of psychopharmacological medication use,
previous mental health problems and smoking, and the
unavailability of these measures from cardiac sample I.
Overall, the results of the present study indicated that
the Icelandic DS14 is a psychometrically sound assessment
tool that can be readily applied in epidemiological and
clinical research. The Type D personality construct was
prevalent in Icelandic cardiac patients, not confounded by
disease severity, and related to certain health-related risk
markers in this clinical population.
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